Multiracial perspectives on ethnoracial categorization in Alzheimer's disease research
Open Access
- 16 July 2026
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Behavior & Socioeconomics of Aging
- Vol. 2 (3) , e70097
Abstract
INTRODUCTION: There is a growing proportion of Alzheimer's disease (AD) research participants identifying as two or more races; however, analyses primarily rely on monoracial categories, resulting in exclusion or recategorization of Multiracial participants. METHODS: We conducted semi‐structured qualitative interviews with 21 Multiracial adults to explore preferences and perceptions of racial categorization and reclassification in AD research. Recruitment prioritized diverse Multiracial identities, and interviews were evaluated using thematic analysis. RESULTS: Participants expressed varied preferences for racial categorization, with many assuming a monoracial standard. Preferences corresponded to both racial identity and assumed racial identification, and depended on available options. Participants responded to reclassification with calls for increased transparency about study methods and intended data usage, and concerns for racial misrepresentation. DISCUSSION: Findings underscore the utility of multiple questions and response options for racial categorization, researcher respect of participant experiences and the evolving nature of classification systems, and clear communication about analytic decisions.Keywords
Funding Information
- National Institute of General Medical Sciences (P20GM109025)
This publication has 56 references indexed in Scilit:
- Assessing Motivation for Engaging in an Alzheimer's Disease Research RegistryAlzheimer's & Dementia, 2025
- Association between trust of researchers and willingness to participate in Alzheimer's disease biomarker researchAlzheimer's & Dementia: Behavior & Socioeconomics of Aging, 2025
- Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adultsAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2023
- A boot camp translation of Alzheimer's disease in Hispanic/Latino communitiesAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2023
- Association of Race and Ethnicity With Incidence of Dementia Among Older AdultsJAMA, 2022
- Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer DiseaseJAMA Network Open, 2022
- Communication about Alzheimer's disease and research among American Indians and Alaska NativesAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
- Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentationAlzheimer's & Dementia, 2021
- Diversity in Alzheimer's disease drug trials: The importance of eligibility criteriaAlzheimer's & Dementia, 2021
- Racial and ethnic differences in older adults’ willingness to be contacted about Alzheimer's disease research participationAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020